Company intelligence / Profile preview

Laureate Pharma

Princeton, New Jersey, United States

Ownership: Private
Employees: ~136
Development stage: Commercial

Overview

Laureate Pharma was a leading biopharmaceutical contract development and manufacturing organization specializing in process development, cGMP production of therapeutic proteins including monoclonal antibodies and Fc-fusion proteins, aseptic filling, cell line development, analytical testing, stability testing, regulatory support, and sustained-release drug formulations. The company served global clients from its Princeton facility since 1981. It was acquired by Safeguard Scientifics and later became part of Saints Capital's portfolio. Its current independent operational status is unclear.

Modalities: Monoclonal antibodyFc-fusion proteinRecombinant proteinSustained-release micro-particle formulations
Industry: Contract Manufacturing Organization

Partnerships

Arius PharmaceuticalsContract Pharma

Beyond the preview

Go deeper on Laureate Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Laureate Pharma.

Explore the full profile